CD4 and COVID-19: Furthermore, our characterization of CD4+ T cells and CD8+ T cells revealed an increased percentage of early or late effector CD8+ T cells in pregnant SARS-CoV-2 infected women compared with post-COVID-19 pregnant women, consistent with a recent publication (35).